Development of a Troponin I Biosensor Using a Peptide Obtained through Phage Display

被引:72
作者
Wu, Jun [1 ,2 ]
Cropek, Donald M. [2 ]
West, Alan C. [1 ]
Banta, Scott [1 ]
机构
[1] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA
[2] USA, Engineer Res & Dev Ctr, Construct Engn Res Lab, Champaign, IL USA
关键词
QUARTZ-CRYSTAL MICROBALANCE; SURFACE-PLASMON RESONANCE; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; TYROSINE-PHOSPHORYLATED PEPTIDES; ACUTE MYOCARDIAL-INFARCTION; FRAGMENT VARIABLE ANTIBODY; CARDIAC TROPONIN; IMPEDIMETRIC IMMUNOSENSOR; BIOCHEMICAL MARKERS; SENSOR;
D O I
10.1021/ac101657h
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A small synthetic peptide with nanomolar affinity for cardiac troponin I (TnI) previously identified from a polyvalent phage displayed library, has been immobilized on a gold surface for TnI detection. The binding affinity of gold-immobilized peptides for TnI was studied and compared with that of phage-immobilized peptides. Quartz crystal microbalance (QCM), cyclic voltammetry, and electrochemical impedance spectroscopy (EIS) were used to monitor both the immobilization and target binding processes. All three techniques show that the binding is specific for TnI as compared to a streptavidin (SA) control. The response curves obtained at TnI concentrations ranging from 0 to 10 mu g/mL, using both QCM and EIS, were also compared. For the EIS measurements, the sensitivity was 0.30 +/- 0.030 normalized impedance/(mu g/mL) and the limit of detection (LOD) was 0.34 mu g/mL. Using the QCM, a sensitivity of 18 +/- 1 Hz/(mu g/mL) was obtained, corresponding to an LOD of 0.11 mu g/mL. Although the QCM demonstrated a lower LOD as compared to EIS, the latter technique exhibited a larger linear dynamic range than QCM. In a relevant tissue culture milieu, Minimum Essential Media (MEM), the sensitivity of the EIS measurement was greater than that obtained in a phosphate buffer system (PBS). The kinetics of target binding using QCM were analyzed by two independent methods, and the dissociation constants (K-D = 66 +/- 4 nM and 17 +/- 8 nM) were an order of magnitude higher than that calculated for the polyvalent phage particles (K-D = 2.5 +/- 0.1 nM). Even though the affinity of the immobilized peptides for Till was somewhat reduced, overall, these results demonstrate that peptides obtained from the biopanning of phage display libraries can be readily used as sensing probes in biosensor development.
引用
收藏
页码:8235 / 8243
页数:9
相关论文
共 73 条
[1]   In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity [J].
Adamcova, Michaela ;
Simunek, Tomas ;
Kaiserova, Helena ;
Popelova, Olga ;
Sterba, Martin ;
Potacova, Anna ;
Vavrova, Jaroslava ;
Malakova, Jana ;
Gersl, Vladmir .
TOXICOLOGY, 2007, 237 (1-3) :218-228
[2]   CARDIAC TROPONIN-I - A MARKER WITH HIGH SPECIFICITY FOR CARDIAC INJURY [J].
ADAMS, JE ;
BODOR, GS ;
DAVILAROMAN, VG ;
DELMEZ, JA ;
APPLE, FS ;
LADENSON, JH ;
JAFFE, AS .
CIRCULATION, 1993, 88 (01) :101-106
[3]   Cardiac troponin assays: Analytical issues and clinical reference range cutpoints [J].
Apple F.S. .
Cardiovascular Toxicology, 2001, 1 (2) :93-98
[4]   Bacteriophage T4 Nanoparticles as Materials in Sensor Applications: Variables That Influence Their Organization and Assembly on Surfaces [J].
Archer, Marie J. ;
Liu, Jinny L. .
SENSORS, 2009, 9 (08) :6298-6311
[5]   Troponin: the biomarker of choice for the detection of cardiac injury [J].
Babuin, L ;
Jaffe, AS .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (10) :1191-1202
[6]  
BARD A.J., 1982, ELECTROCHEMICAL METH
[7]   On the response of a label-free interferon-γ immunosensor utilizing electrochemical impedance spectroscopy [J].
Bart, M ;
Stigter, ECA ;
Stapert, HR ;
de Jong, GJ ;
van Bennekom, WP .
BIOSENSORS & BIOELECTRONICS, 2005, 21 (01) :49-59
[8]  
Berggren C, 2001, ELECTROANAL, V13, P173, DOI 10.1002/1521-4109(200103)13:3<173::AID-ELAN173>3.0.CO
[9]  
2-B
[10]   Evaluation of a new ultrasensitive assay for cardiac troponin I [J].
Casals, Gregori ;
Filella, Xavier ;
Bedini, Josep Lluis .
CLINICAL BIOCHEMISTRY, 2007, 40 (18) :1406-1413